Skip to content
Sunday, November 8, 2026
Stay updated with the latest news, stories, and analysis on…

Giving Stem Cells in Utero to Babies with Neural Tube Defect Improves Quality of Life, Research Shows

A groundbreaking research effort has found that administering stem cells to unborn babies diagnosed with spina bifida during corrective surgery can be a "significant breakthrough" in treating birth defects.

Trial Details and Safety

The research conducted in the United States focused on six unborn babies with a severe neural tube defect. Surgeons applied placenta-derived mesenchymal stem cells directly onto the infant's spine as part of the surgical correction.

Significantly, the regenerative treatment proved to be secure. Doctors verified that the treatment did not lead to tumors, interfere with wound healing, or prevent the reversal of co-occurring hindbrain herniation.

Promising Outcomes

Post-birth MRI scans confirmed a complete reversal of brainstem displacement in each of the babies. This brain structure normalization is closely linked to better mobility and function.

"If it makes additional babies to achieve ambulation who wouldn't have, it could establish itself as their standard of care," said the lead researcher. "These findings are extremely promising and open the door to lots of potential novel therapies."

Long-Term Prospects and Optimism

Experts not involved in the trial proposed that further confirmation of these observed advantages could signal a "fresh chapter" in in-utero treatment. The potential to improve neurological damage seen in utero is considered a revolutionary objective.

Especially significant would be improvements in bladder and bowel function, which are typical difficulties for those diagnosed with this disorder.

The Path Forward

Although this preliminary study focused on a handful of cases, its safety demonstration and positive signals provide a strong foundation for broader investigative efforts. The addition of cellular treatment with proven prenatal surgical methods holds considerable promise for transforming outcomes for babies yet to be born with myelomeningocele.

By

Susan Harris

A journalist specializing in royal affairs with over a decade of experience covering European monarchies and their global impact.

Royal Update

Type to search articles.